Anticancer Research: 44 (10)

October 2024; Volume 44,Issue 10

Reviews

Open Access
True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
KOZO KURIBAYASHI and JUN HIRANO

Anticancer Research October 2024, 44 (10) 4135-4145; DOI: https://doi.org/10.21873/anticanres.17244
Open Access
Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target
HIROTAKA SUTO

Anticancer Research October 2024, 44 (10) 4147-4153; DOI: https://doi.org/10.21873/anticanres.17245
Open Access
Side-effects of Phytotherapeutics in Cancer Care – A Review of Inconsistencies in National and International Databases
JULIANE BÜTTNER, JUDITH BÜNTZEL, JENS BÜNTZEL and JUTTA HÜBNER

Anticancer Research October 2024, 44 (10) 4155-4164; DOI: https://doi.org/10.21873/anticanres.17246

Experimental Studies

Open Access
Tumor Dormancy Within the Lymphovascular Embolus Is Regulated by Multiple Metabolism-signaling Pathways
YIN YE, JUSTIN WANG, JORDAN DILLARD and SANFORD H. BARSKY

Anticancer Research October 2024, 44 (10) 4165-4173; DOI: https://doi.org/10.21873/anticanres.17247
Open Access
Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis
AAKASH NATHANI, ISLAUDDIN KHAN, MATHEUS HIKARU TANIMOTO, JENNYFER ANDREA ALDANA MEJÍA, ALINE MAYRINK DE MIRANDA, ARUN RISHI, SATYANARAYAN DEV, JAIRO KENUPP BASTOS and MANDIP SINGH

Anticancer Research October 2024, 44 (10) 4175-4188; DOI: https://doi.org/10.21873/anticanres.17248
Open Access
Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma Cells
REEMA SAMI ISSA, MEIKE KAEHLER, NINA SOPHIE POMMERT, INGOLF CASCORBI and VICKI WAETZIG

Anticancer Research October 2024, 44 (10) 4189-4202; DOI: https://doi.org/10.21873/anticanres.17249
Open Access
TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
TIM SVENSTRUP POULSEN, ANDERS NYGAARD LØRUP, PER KONGSTED, RIKKE LØVENDAHL EEFSEN, MARTIN HØJGAARD and ESTRID VILMA HØGDALL

Anticancer Research October 2024, 44 (10) 4203-4211; DOI: https://doi.org/10.21873/anticanres.17250
Open Access
Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research October 2024, 44 (10) 4213-4218; DOI: https://doi.org/10.21873/anticanres.17251
Open Access
Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3D In Vitro Cultures
KATARZYNA UNRUG-BIELAWSKA, DAVID EARNSHAW, MAGDALENA CYBULSKA-LUBAK, EWELINA KANIUGA, ZUZANNA SANDOWSKA-MARKIEWICZ, MALGORZATA STATKIEWICZ, IZABELA RUMIENCZYK, MICHALINA DĄBROWSKA, JUSTYNA KOCIK-KROL, KRZYSZTOF KLIMKIEWICZ, MAGDALENA URBANOWICZ, BEATA NAUMCZUK, LECH KOZERSKI, MARCIN KRZYKAWSKI, MICHAL MIKULA and JERZY OSTROWSKI

Anticancer Research October 2024, 44 (10) 4219-4224; DOI: https://doi.org/10.21873/anticanres.17252
Open Access
Impacts of Matrix Metalloproteinase-8 Genotypes, Smoking, Alcohol Drinking, and Helicobacter Pylori Infection on Gastric Cancer
CHUN-KAI FU, WEI-CHING CHIEN, YING-JING CHEN, MEI-DUE YANG, JAW-CHYUN CHEN, TAO-WEI KE, CHIA-WEN TSAI, WEN-SHIN CHANG, YI-CHIH HUNG and DA-TIAN BAU

Anticancer Research October 2024, 44 (10) 4225-4232; DOI: https://doi.org/10.21873/anticanres.17253
You have access
Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis
RUJIA LI, TING YANG, KE REN, JUN LI, YUICHI NAGAKAWA, YUHAO ZENG, YUTARO NATSUYAMA and SHUANG-QIN YI

Anticancer Research October 2024, 44 (10) 4233-4250; DOI: https://doi.org/10.21873/anticanres.17254
You have access
Sparing Effect on Cell Survival Under Normoxia Using Ultra-high Dose Rate Proton Beams from a Compact Superconducting AVF Cyclotron
MASASHI YAGI, KAZUMASA MINAMI, KAZUKI FUJITA, SHINJI NOMURA, NAGAAKI KAMIGUCHI, KANA NAGATA, RYO HIDANI, DAIZO AMANO, KENZO SASAI, SHINICHI SHIMIZU and KAZUHIKO OGAWA

Anticancer Research October 2024, 44 (10) 4251-4260; DOI: https://doi.org/10.21873/anticanres.17255
You have access
Characterization of Molecular Subtypes of Rat Mammary Cancer and Their Association With Environmental Exposures
YUKIKO NISHIMURA, DAISUKE IIZUKA, MASARU TAKABATAKE, KAZUHIRO DAINO, MAYUMI NISHIMURA, TAKAMITSU MORIOKA, YOSHIYA SHIMADA, SHIZUKO KAKINUMA and TATSUHIKO IMAOKA

Anticancer Research October 2024, 44 (10) 4261-4272; DOI: https://doi.org/10.21873/anticanres.17256
You have access
Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer
HEEEUN HA, JI-YOON RYU, SUIN YOON, YOUNG-JAE CHO, JUNG-JOO CHOI, JAE RYOUNG HWANG, JU-YEON CHOI, HEE DONG HAN and JEONG-WON LEE

Anticancer Research October 2024, 44 (10) 4273-4282; DOI: https://doi.org/10.21873/anticanres.17257
You have access
MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK

Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
You have access
Repurposing Valrubicin as a Potent Inhibitor of Ovarian Cancer Cell Growth
JAEEUN LEE and KYUN HEO

Anticancer Research October 2024, 44 (10) 4301-4307; DOI: https://doi.org/10.21873/anticanres.17259
You have access
Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma
HYEON JI KIM and DO-YEON KIM

Anticancer Research October 2024, 44 (10) 4309-4315; DOI: https://doi.org/10.21873/anticanres.17260
You have access
Methyl Gallate Suppresses Canine Mammary Gland Tumors by Inducing Apoptosis and Anti-angiogenesis
JAWUN CHOI, JI-YOUNG CHOI, HYUK JANG, YE-JI JANG, JUN SONG, GYU-MIN KIM and JAE-WON SEOL

Anticancer Research October 2024, 44 (10) 4317-4326; DOI: https://doi.org/10.21873/anticanres.17261
You have access
Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung Cancer Xenograft Models
PO-JU LIN, YU-CHENG KUO, PO-WEI HU, WEI-LUNG CHEN, SHIH-CHIEH CHANG, FEI-TING HSU, JENG-YUAN WU and JIANN-HWA CHEN

Anticancer Research October 2024, 44 (10) 4327-4337; DOI: https://doi.org/10.21873/anticanres.17262
You have access
5,10,15,20-Tetrakis(4-sulfonatophenyl)porphyrin Zinc and Chloro-aluminum Phthalocyanine Disulfonate in Photodynamic Therapy of Colorectal Adenocarcinoma In Vitro
JAKUB HOSIK, BARBORA HOSIKOVA, HANA KOLAROVA and ROBERT BAJGAR

Anticancer Research October 2024, 44 (10) 4339-4346; DOI: https://doi.org/10.21873/anticanres.17263
You have access
Promising Approach for Optimizing In Vivo Fluorescence Imaging in a Tumor Mouse Model: Precision in Cancer Research
YU-JEONG CHOI, SONNY C. RAMOS, HYUN BO SIM, JI YEON HAN, DAE-HAN PARK, SEUL-KI MUN, JU-BIN LEE, CHI-HO LEE, YONG-AN LEE and JONG-JIN KIM

Anticancer Research October 2024, 44 (10) 4347-4358; DOI: https://doi.org/10.21873/anticanres.17264
You have access
Inhibition of Epithelial–Mesenchymal Transition and Migration in Cisplatin-resistant Cancer Through Combined Treatment With Cisplatin and SH003
HYEONG SIM CHOI, JEONG-KUI KU, SEONG-GYU KO and PIL-YOUNG YUN

Anticancer Research October 2024, 44 (10) 4359-4369; DOI: https://doi.org/10.21873/anticanres.17265

Clinical Studies

Open Access
Nondysplastic Colon Crypts Intercalated in Tubular Adenomas Support Field Cancerization
CARLOS A. RUBIO, MICHAEL VIETH and CORINNA LANG-SCHWARZ

Anticancer Research October 2024, 44 (10) 4371-4377; DOI: https://doi.org/10.21873/anticanres.17266
Open Access
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
MICHELE DIONESE, DAVIDE BIMBATTI, FRANCESCO PIERANTONI, ELEONORA LAI, ELISA ERBETTA, NICOLÒ CAVASIN, SALIM JUBRAN, UMBERTO BASSO and MARCO MARUZZO

Anticancer Research October 2024, 44 (10) 4379-4386; DOI: https://doi.org/10.21873/anticanres.17267
Open Access
Identifying High Recurrence Risk in Breast Carcinoma Patients Through Spatial Transcriptomic Analysis
JINAH CHU, SUNG-IM DO and HYUN-SOO KIM

Anticancer Research October 2024, 44 (10) 4387-4401; DOI: https://doi.org/10.21873/anticanres.17268
Open Access
Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients
JAN LEPPERT, CLAUDIA DITZ, MAXIMILIAN GROHMANN, CHRISTIAN ZIEMANN, CHRISTINA HILLBRICHT, LARYSA LIUBICH, MARIA VITTORIA MATONE, DIRK RADES, JAN GLIEMROTH and ANASTASSIA LÖSER

Anticancer Research October 2024, 44 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.17269
Open Access
Factors Limiting Ostomy Reversal After Cytoreductive Surgery for Ovarian Cancer: A Retrospective Study
BEATRIZ NAVARRO SANTANA, FREDERIC GUYON, OCTAVIO ARENCIBIA, GUILLAUME BABIN, EUDALDO TOMMASETTI, DANIEL GONZÁLEZ, SABRINA PIEDIMONTE and ALICIA MARTÍN MARTÍNEZ

Anticancer Research October 2024, 44 (10) 4413-4418; DOI: https://doi.org/10.21873/anticanres.17270
Open Access
Palliative Radiation Treatment in Patients Managed With Advanced/Interventional Pain Therapy such as Pump-delivered Continuous Opioids
CARSTEN NIEDER, STINE M. JENSEN, SOLVEIG NILSEN and ELLINOR C. HAUKLAND

Anticancer Research October 2024, 44 (10) 4419-4425; DOI: https://doi.org/10.21873/anticanres.17271
Open Access
Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma
VINCENT HARLAY, ALEXANDRE BERTUCCI, CÉLINE BOUCARD, GREGORIO PETRIRENA, CHANTAL CAMPELLO, MARYLINE BARRIÉ, DIDIER AUTRAN, OLIVIER CHINOT and EMELINE TABOURET

Anticancer Research October 2024, 44 (10) 4427-4433; DOI: https://doi.org/10.21873/anticanres.17272
You have access
Predictive Biomarkers of Lymph Node Metastasis in Early Gastric Cancer: A Reference of Clinicopathological Characteristics, Protein Expression, Epstein-Barr Virus Status, and Microsatellite Instability
SUN-JU BYEON, MEE SOO CHANG, HYE EUN PARK, DOEHEE KANG, YUTING WANG, DONG-SEOK HAN, HYE SUNG AHN, SEUNG CHUL HEO, MYONG SEOK LEE, WON KIM, SU HWAN KIM, DONG-WON AHN and KOOK LAE LEE; on behalf of the Gastrointestinal Diseases Study Group of Seoul National University Boramae Hospital

Anticancer Research October 2024, 44 (10) 4435-4448; DOI: https://doi.org/10.21873/anticanres.17273
Open Access
Intraoperative Bleeding Complications Leading to Blood Transfusions (BloTs) in 17,412 Cholecystectomies in Finland: A Study With Special Reference to Elderly Patients
ANTTI KIVIVUORI, PEKKA LAMMI, MATTI ESKELINEN, TUOMO RANTANEN, HANNU PAAJANEN, JUKKA PULKKINEN and MIKA UKKONEN

Anticancer Research October 2024, 44 (10) 4449-4456; DOI: https://doi.org/10.21873/anticanres.17274
Open Access
Changes in Bladder Volume During Radiotherapy for Prostate Cancer
DIRK RADES, FLORIAN CREMERS, CHRISTIAN ZIEMANN, LAURA SPLETTSTÖSSER, CARLOS A. NARVAEZ-WOLF, AHMED AL-SALOOL, MICHAEL VON STADEN, JAN-DIRK KÜTER, STEFAN JANSSEN and CARMEN TIMKE

Anticancer Research October 2024, 44 (10) 4457-4463; DOI: https://doi.org/10.21873/anticanres.17275
You have access
Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors
EDOARDO VIRGILIO, CARLO SALVEMINI, MARIA GRAZIA TREGLIA, ELENA THAI, EVA FRANCHI, SARA PANICO, LUIGI IPPOLITO, CLARA PAVLIDIS, ALFREDO ANNICCHIARICO, ENRICO MARIA SILINI and RENATO COSTI

Anticancer Research October 2024, 44 (10) 4465-4481; DOI: https://doi.org/10.21873/anticanres.17276
Open Access
Contribution of Immunoscore to Survival Prediction in Pancreatic Ductal Adenocarcinoma
HARUKI MORI, TORU MIYAKE, HIROMITSU MAEHIRA, MASANORI SHIOHARA, HIROYA IIDA, NOBUHITO NITTA and MASAJI TANI

Anticancer Research October 2024, 44 (10) 4483-4492; DOI: https://doi.org/10.21873/anticanres.17277
You have access
Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA

Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
You have access
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
INSU KIM, SUN HA CHOI, SHIN YUP LEE, SEUNG SOO YOO, JI EUN PARK, KYEONG-CHEOL SHIN, JONG GEOL JANG, KYUNG SOO HONG, YONG SHIK KWON, SUN HYO PARK, KEUM-JU CHOI, CHI YOUNG JUNG, MI-HYUN KIM, SOO HAN KIM, HEE YUN SEOL, JEHUN KIM, JIN-HAN PARK, TAE HOON KIM, JUNG SEOP EOM and JUNE HONG AHN

Anticancer Research October 2024, 44 (10) 4505-4516; DOI: https://doi.org/10.21873/anticanres.17279
You have access
Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer
AKIHIRO TSUKAGUCHI, AKIHIRO TAMIYA, SHOICHI FUKUDA, YUKI IWAHASHI, KENSUKE KANAOKA, YUYA TANAKA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, TOMOKO KAGAWA, YOSHINOBU MATSUDA and KYOICHI OKISHIO

Anticancer Research October 2024, 44 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.17280
You have access
CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
NATSUKI UENAKA, EIICHI SATO, YOSHIYA HORIMOTO, SAORI KAWAI, MARIKO ASAOKA, HIROSHI KAISE, KIMITO YAMADA and TAKASHI ISHIKAWA

Anticancer Research October 2024, 44 (10) 4525-4536; DOI: https://doi.org/10.21873/anticanres.17281
You have access
Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy
TAKASHI OSHIMA, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, YAYOI KIMURA, MIE TANABE, YUTA NAKAYAMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA and YOHEI MIYAGI

Anticancer Research October 2024, 44 (10) 4537-4542; DOI: https://doi.org/10.21873/anticanres.17282
You have access
Radiation-induced Esophagitis in Breast Cancer Patients Treated With Supraclavicular Field Irradiation
ZAHRA MOHAMMED AHMED, MOHAMED ABOUEGYLAH, GEHAN A. KHEDR, HANS THEODOR EICH, KHALED ELSAYAD and ASHRAF MAHMOUD ELENBABY

Anticancer Research October 2024, 44 (10) 4543-4549; DOI: https://doi.org/10.21873/anticanres.17283
You have access
The Dominant Component and Clinicopathological Characteristics of Combined Hepatocellular-cholangiocarcinoma After Radical Resection
KEISO MATSUBARA, TSUYOSHI KOBAYASHI, TAKESHI TADOKORO, YOSUKE NAMBA, SOTARO FUKUHARA, KO OSHITA, NARUHIKO HONMYO, SHINTARO KURODA, KOJI ARIHIRO and HIDEKI OHDAN

Anticancer Research October 2024, 44 (10) 4551-4559; DOI: https://doi.org/10.21873/anticanres.17284
You have access
Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression
RYO MIYAKE, HIROSHI TAKEYAMA, YOSHINOBU MANOME, MUNEYUKI KOYAMA, ISAO TABEI, HISASHI SHIOYA, TAKASHI KAZAMA and HIROKO NOGI

Anticancer Research October 2024, 44 (10) 4561-4568; DOI: https://doi.org/10.21873/anticanres.17285
You have access
Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy
SHINNOSUKE KAWAHARA, TORU AOYAMA, ITARU HASHIMOTO, REI KANEMOTO, NAOHIKO MATSUSHITA, MARIKO KAMIYA, YOSUKE ATSUMI, YUKIO MAEZAWA, KEISUKE KAZAMA, MASAAKI MURAKAWA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and SOICHIRO MORINAGA

Anticancer Research October 2024, 44 (10) 4569-4577; DOI: https://doi.org/10.21873/anticanres.17286
You have access
Clinical Significance of HRNR Expression in Patients With Stage II/III Gastric Cancer After Curative Gastrectomy
TAKASHI OSHIMA, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, YAYOI KIMURA, MIE TANABE, YUTA NAKAYAMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA and YOHEI MIYAGI

Anticancer Research October 2024, 44 (10) 4579-4584; DOI: https://doi.org/10.21873/anticanres.17287
You have access
Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer
YONG MIN NA, SANG CHUN PARK, SANG YUN AN, HYE UN MA, YONG BIN KWON, YOUNG JAE RYU, JIN SEONG CHO and MIN HO PARK

Anticancer Research October 2024, 44 (10) 4585-4592; DOI: https://doi.org/10.21873/anticanres.17288
You have access
Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy
RYOSUKE KUGA, KAZUKI HASHIMOTO, HIDETAKA YAMAMOTO, MIDORI TANIGUCHI, TOMOMI MANAKO, MASANOBU SATO, RYUNOSUKE KOGO, MIOKO MATSUO, YOSHINAO ODA and TAKASHI NAKAGAWA

Anticancer Research October 2024, 44 (10) 4593-4603; DOI: https://doi.org/10.21873/anticanres.17289
You have access
Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation
LILY XU, AMANDA TIAN, RUOHAO FAN and JINPING LAI

Anticancer Research October 2024, 44 (10) 4605-4608; DOI: https://doi.org/10.21873/anticanres.17290
You have access
Awake Surgery for Right Frontal Lobe Glioma: Preserving Emotional Recognition and Facilitating Early Return to Work
KOSEI YAMAMOTO, RYOTA TAMURA, SOTA WAKAHARA, KAZUHIRO KOJIMA, MAKIKO ANDO, MASAHIRO YO, KENZO KOSUGI, YOHEI KITAMURA, RYO UEDA, AIKO ISHIKAWA, TETSUYA TSUJI and MASAHIRO TODA

Anticancer Research October 2024, 44 (10) 4609-4615; DOI: https://doi.org/10.21873/anticanres.17291

Abstracts of the 34th Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

Open Access
ABSTRACTS OF THE 34th ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIUrO)
Anticancer Research October 2024, 44 (10) 4617-4661; DOI: https://doi.org/10.21873/anticanres.17292

Corrigenda

Open Access
Corrigenda
Anticancer Research October 2024, 44 (10) 4663; DOI: https://doi.org/10.21873/anticanres.17293

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

Abstracts of the 34th Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

Corrigenda

In this issue

Issue highlights

Jump to